Date: Monday, 2nd September 2019
Time: 13h30 – 14h00
A “Very Low Calorie Diet” (VLCD) is a low carbohydrate, total food replacement for the dietary management of obesity. It provides 800 calories or less per day, whilst consisting of sufficient protein, fatty acids, carbohydrates, vitamins and minerals for safe and rapid weight loss.
The OPTIFAST® Programme is based on a very low calorie diet (VLCD), which provides roughly 800 kcal of energy per day for the first 8 weeks as part of a managed weight loss programme.
The Programme has shown to significantly reduce body weight by 1-2.5 kg per week with greater weight loss than other forms of calorie restriction. Most overweight and obese patients with Type 1 or Type 2 diabetes are eligible to use OPTIFAST VLCD as part of an overall management program that emphasises the importance of ongoing weight maintenance.
The OPTIFAST® Programme was launched in South Africa in 2017 in partnership with the Centre for Diabetes and Endocrinology (CDE) as a pilot project under the supervision of accredited Registered Dietitians. OPTIFAST® Programme is a structured nutritional and behavioural change programme developed by leading experts and supported by medical professionals.
Speaker: Lynne Mincher
Affiliation: NESTLÉ Health Science (NESTLÉ South Africa)
Lynne Mincher is a Registered Dietitian, and currently Medical Marketing and Scientific Affairs Manager at NESTLÉ Health Science, South Africa.
Lynne started her career as a Clinical Dietitian, completing her internship at King Edward VIII Hospital in KZN before taking up a post in the at St Helier Hospital in Surrey, UK, working in ICU and general medical and surgical wards. Lynne joined NESTLÉ Healthcare Nutrition, UK in a Scientific Affairs role for Medical Nutrition Products, before moving back to South Africa to NESTLÉ, where she has worked on a Public Affairs Programme with the Department of Basic Education rolling out the NESTLÉ Healthy Kids Programme in Primary Schools; Nutrition Health & Wellness, and more recently on the OPTIFAST Programme in South Africa with NESTLÉ Health Sciences.